Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation

NCT06570096 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Premixed
Sequential
Lidocaine
Bupivacaine
Supraclavicular Brachial Plexus Block
Arteriovenous Fistula

Interventions

DRUG: Lidocaine 2% then bupivacaine 0.5%
DRUG: Lidocaine 2% and bupivacaine 0.5%

Sponsor

Tanta University